JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 45:1076-1080, doi:10.1016/j.jacc.2004.12.067
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Autore, C.
Right arrow Articles by Spirito, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Autore, C.
Right arrow Articles by Spirito, P.

CLINICAL RESEARCH: CARDIOMYOPATHY

The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms

Camillo Autore, MD*,*, Paola Bernabò, MD{dagger}, Caterina Stella Barillà, MD*, Paolo Bruzzi, MD, PhD{ddagger} and Paolo Spirito, MD{dagger}

* Divisione di Cardiologia, Ospedale Sant'Andrea, Università "La Sapienza", Rome
{dagger} Divisione di Cardiologia, Ente Ospedali Galliera, Genoa
{ddagger} Servizio di Epidemiologia Clinica, Istituto Nazionale Ricerca sul Cancro, Genoa, Italy

Manuscript received May 28, 2004; revised manuscript received November 2, 2004, accepted December 21, 2004.

* Reprint requests and correspondence: Dr. Camillo Autore, Università di Roma "La Sapienza", Ospedale Sant'Andrea, Via Grottarossa 1035–1039; 00189 Rome, Italy (Email: camillo.autore{at}uniroma1.it).

OBJECTIVES: The aim of this study was to investigate whether the prognostic importance of left ventricular (LV) outflow obstruction in hypertrophic cardiomyopathy (HCM) is influenced by other predictors of morbidity and mortality.

BACKGROUND: It remains unknown whether the effect of outflow obstruction on clinical outcome in HCM is influenced by other determinants of survival.

METHODS: We assessed the impact of severity of symptoms, LV wall thickness, atrial fibrillation, and age on the prognostic importance of outflow obstruction in a large HCM population.

RESULTS: Of 526 consecutive HCM patients, 141 (27%) had outflow obstruction. During a follow-up of 4.5 ± 4.1 years, 34 patients died of HCM. The incidence of cardiovascular death was significantly higher among patients with LV obstruction than among those without obstruction (relative risk [RR] = 2.14; p = 0.02). The prognostic power of the outflow gradient changed in relation to severity of symptoms (p = 0.024). At initial evaluation, LV obstruction was a significant predictor of cardiovascular mortality only in New York Heart Association (NYHA) functional class I to II patients (hazard ratio [HR] = 2.38; p = 0.025). During follow-up, at time of development of severe symptoms, the outflow gradient lost its prognostic significance (HR = 1.18; p = 0.66), whereas NYHA functional class III to IV was associated with an eight-fold increase in risk of cardiovascular mortality (HR = 7.90; p < 0.001).

CONCLUSIONS: In patients with HCM, the prognostic importance of LV outflow obstruction varies in relation to the severity of symptoms. In patients with mild or no symptoms, obstruction is an important predictor of cardiovascular death. After development of severe symptoms, NYHA functional class becomes the dominant marker of prognosis independently of the presence of an outflow gradient.

Abbreviations and Acronyms
  AF = atrial fibrillation
  CI = confidence interval
  HCM = hypertrophic cardiomyopathy
  HR = hazard ratio
  LV = left ventricular
  NYHA = New York Heart Association




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
I. Olivotto, M. S. Maron, C. Autore, J. R. Lesser, L. Rega, G. Casolo, M. De Santis, G. Quarta, S. Nistri, F. Cecchi, et al.
Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol., August 12, 2008; 52(7): 559 - 566.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. S. Maron, I. Olivotto, A. G. Zenovich, M. S. Link, N. G. Pandian, J. T. Kuvin, S. Nistri, F. Cecchi, J. E. Udelson, and B. J. Maron
Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction
Circulation, November 21, 2006; 114(21): 2232 - 2239.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. M. Elliott, J. R. Gimeno, M. T. Tome, J. Shah, D. Ward, R. Thaman, J. Mogensen, and W. J. McKenna
Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy
Eur. Heart J., August 2, 2006; 27(16): 1933 - 1941.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
P. Spirito and C. Autore
Management of hypertrophic cardiomyopathy.
BMJ, May 27, 2006; 332(7552): 1251 - 1255.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.